Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

209.80p
   
  • Change Today:
      2.20p
  • 52 Week High: 213.69
  • 52 Week Low: 94.55
  • Currency: UK Pounds
  • Shares Issued: 725.54m
  • Volume: 1,986,073
  • Market Cap: 1,522.19m
  • RiskGrade: 314

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-21 Interim 381.00 119.00 12.00¢ n/a

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 1,058.00 98.00 35.00¢ 11.6 3.9 +3% n/a 0.0%
31-Dec-17 1,093.00 137.00 37.00¢ 15.1 2.5 +6% n/a 0.0%
31-Dec-18 1,005.00 278.00 37.00¢ 4.1 n/a n/a n/a 0.0%
31-Dec-19 785.00 180.00 24.00¢ 2.2 n/a -35% n/a 0.0%
31-Dec-20 647.00 (173.00) 8.00¢ 18.6 n/a -67% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 534.36 89.69 9.65p 21.8 0.3 +66% n/a 0.0%
31-Dec-22 578.99 135.05 15.22p 13.8 0.2 +58% n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 18.58 2.15 9.99 3.58

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Indivior Market Data

Currency UK Pounds
Share Price 209.80p
Change Today 2.20p
% Change 1.06 %
52 Week High 213.69
52 Week Low 94.55
Volume 1,986,073
Shares Issued 725.54m
Market Cap 1,522.19m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.38% below the market average38.38% below the market average38.38% below the market average38.38% below the market average38.38% below the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
94.95% above the market average94.95% above the market average94.95% above the market average94.95% above the market average94.95% above the market average
93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average93.55% above the sector average
Income Not Available
Growth
68.96% below the market average68.96% below the market average68.96% below the market average68.96% below the market average68.96% below the market average
83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average83.33% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 20-Sep-2021

Time Volume / Share Price
16:35 9,706 @ 209.80p
16:35 18,003 @ 209.80p
16:35 475,903 @ 209.80p
16:29 26 @ 209.20p
16:29 275 @ 209.33p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page